Latest Ratios: P/E Ratio -25.3x · EV/EBITDA 14.5x · ROE -4.1%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $19.4B | $16.9B | $13.4B | $14.5B | $14.3B | $18.4B | $21.9B | $20.0B | $24.6B | $22.6B | $12.8B |
| Enterprise Value | $21.8B | $19.3B | $18.7B | $19.9B | $18.8B | $27.6B | $35.4B | $36.5B | $28.7B | $43.2B | $27.5B |
| P/E Ratio → | -25.28 | — | 18.99 | 34.24 | 2.47 | 2.85 | — | 40.09 | 6.43 | 15.53 | 3.23 |
| P/S Ratio | 2.83 | 2.46 | 1.08 | 1.20 | 1.10 | 1.46 | 1.53 | 0.93 | 1.09 | 0.36 | 0.26 |
| P/B Ratio | 1.40 | 1.19 | 0.56 | 0.59 | 0.53 | 0.68 | 0.56 | 0.48 | 0.26 | 0.22 | 0.47 |
| P/FCF | 17.99 | 15.62 | 10.58 | 9.24 | — | 13.23 | 7.54 | — | 26.63 | — | 7.92 |
| P/OCF | 13.74 | 11.93 | 7.26 | 6.63 | 24.39 | 8.06 | 5.34 | 14.23 | 5.13 | — | 2.33 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.82 | 1.51 | 1.65 | 1.44 | 2.20 | 2.47 | 1.70 | 1.27 | 0.69 | 0.57 |
| EV / EBITDA | 14.50 | 12.80 | 6.20 | 6.96 | 5.94 | 9.27 | 10.37 | 7.52 | 6.64 | 3.87 | 3.09 |
| EV / EBIT | 25.40 | 37.60 | 12.03 | 22.15 | 9.67 | 14.03 | — | 188.18 | 43.77 | 18.97 | 5.22 |
| EV / FCF | — | 17.88 | 14.78 | 12.68 | — | 19.88 | 12.19 | — | 31.06 | — | 17.08 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 30.3% | 30.3% | 31.6% | 30.1% | 30.9% | 32.1% | 30.4% | 29.8% | 27.7% | 21.4% | 21.9% |
| Operating Margin | 12.6% | 12.6% | 14.8% | 14.2% | 15.5% | 14.9% | 14.2% | 13.0% | 9.5% | 11.5% | 12.6% |
| Net Profit Margin | -11.4% | -11.4% | 5.7% | 3.5% | 45.1% | 51.5% | -20.6% | 2.3% | 16.9% | 2.3% | 8.9% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -4.1% | -4.1% | 2.9% | 1.6% | 21.7% | 19.6% | -7.3% | 0.7% | 3.9% | 2.2% | 16.1% |
| ROA | -2.7% | -2.7% | 1.9% | 1.1% | 13.5% | 11.1% | -4.2% | 0.4% | 2.0% | 1.1% | 5.8% |
| ROIC | 2.8% | 2.8% | 4.6% | 4.2% | 4.5% | 3.2% | 2.8% | 2.6% | 1.4% | 6.6% | 11.8% |
| ROCE | 3.4% | 3.4% | 5.4% | 4.7% | 5.2% | 3.8% | 3.4% | 3.2% | 1.5% | 6.2% | 9.8% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.23 | 0.23 | 0.30 | 0.32 | 0.30 | 0.41 | 0.41 | 0.43 | 0.13 | 0.33 | 0.78 |
| Debt / EBITDA | 2.12 | 2.12 | 2.37 | 2.72 | 2.56 | 3.76 | 4.70 | 3.71 | 2.93 | 3.05 | 2.40 |
| Net Debt / Equity | — | 0.17 | 0.22 | 0.22 | 0.16 | 0.34 | 0.35 | 0.40 | 0.04 | 0.20 | 0.54 |
| Net Debt / EBITDA | 1.62 | 1.62 | 1.76 | 1.89 | 1.40 | 3.10 | 3.96 | 3.39 | 0.95 | 1.85 | 1.66 |
| Debt / FCF | — | 2.26 | 4.20 | 3.44 | — | 6.65 | 4.65 | — | 4.43 | — | 9.16 |
| Interest Coverage | 1.64 | 1.64 | 4.26 | 2.27 | 3.94 | 3.75 | -2.34 | 0.29 | 11.91 | — | 6.14 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.42 | 2.42 | 1.33 | 2.43 | 3.02 | 2.90 | 2.37 | 1.20 | 1.73 | 1.91 | 1.88 |
| Quick Ratio | 1.91 | 1.91 | 0.88 | 1.73 | 2.40 | 2.48 | 2.18 | 0.68 | 1.67 | 1.26 | 1.29 |
| Cash Ratio | 0.33 | 0.33 | 0.39 | 0.77 | 1.33 | 0.40 | 0.21 | 0.18 | 0.12 | 0.55 | 0.52 |
| Asset Turnover | — | 0.32 | 0.34 | 0.31 | 0.31 | 0.27 | 0.20 | 0.31 | 0.12 | 0.33 | 0.61 |
| Inventory Turnover | 4.08 | 4.08 | 3.98 | 3.93 | 3.86 | 4.09 | 4.17 | 3.50 | 3.98 | 2.89 | 5.11 |
| Days Sales Outstanding | — | 88.95 | 64.80 | 71.68 | 70.61 | 62.71 | 61.63 | 65.05 | 54.78 | 98.68 | 68.41 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 3.0% | 3.5% | 4.7% | 4.5% | 4.5% | 3.4% | 4.0% | 8.0% | 14.2% | 15.0% | 19.3% |
| Payout Ratio | — | — | 90.3% | 153.9% | 11.1% | 9.7% | — | 324.1% | 91.2% | 234.6% | 57.3% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 5.3% | 2.9% | 40.4% | 35.1% | — | 2.5% | 15.5% | 6.4% | 31.0% |
| FCF Yield | 5.6% | 6.4% | 9.5% | 10.8% | — | 7.6% | 13.3% | — | 3.8% | — | 12.6% |
| Buyback Yield | 2.6% | 3.0% | 3.7% | 13.8% | 30.5% | 11.7% | 1.1% | 11.6% | 18.0% | 4.4% | 7.2% |
| Total Shareholder Yield | 5.6% | 6.5% | 8.5% | 18.3% | 35.0% | 15.1% | 5.1% | 19.7% | 32.2% | 19.4% | 26.5% |
| Shares Outstanding | — | $140M | $140M | $150M | $166M | $181M | $245M | $249M | $257M | $178M | $125M |
PFAS litigation and divestiture
According to current market data, DuPont trades at a forward P/E of 51.06, a multiple that appears to reflect significant investor uncertainty regarding the earnings power of the post-divestiture entity rather than a traditional valuation of its specialty chemical assets compared to historical norms.
The elevated forward multiple suggests that the market is pricing in a recovery in earnings that has yet to materialize in the reported figures. Investors should monitor whether the current P/S of 2.73 represents a floor for the new, leaner business model or if further multiple compression is likely as the company attempts to prove its organic growth potential.
As reported in financial statements, DuPont's ROIC has languished near 0.8% to 1.4% over the last ten quarters, indicating that the company is currently failing to generate returns on invested capital that exceed its cost of capital during this period of intense portfolio restructuring.
The persistent low ROIC suggests that the capital-intensive nature of the remaining specialty chemical assets is not yet being offset by the higher margins expected from the new business configuration. This trend warrants further investigation into whether the company's R&D investments are effectively translating into the 'qualified-in' status required for long-term value creation.
Based on the latest quarterly data, DuPont's cash conversion cycle has remained elevated at 111 days in 2026Q1, a figure that highlights the operational friction and inventory management challenges inherent in transitioning to a more focused specialty materials portfolio compared to historical efficiency levels.
The high DSO and DIO metrics suggest that the company may be facing difficulties in optimizing its supply chain following the recent divestitures. Investors should monitor whether these efficiency metrics improve as the company stabilizes its operations and sheds the complexity associated with its former, more diversified business structure.
According to recent SEC filings, DuPont has successfully reduced its debt-to-equity ratio to 0.22 as of 2026Q1, a significant improvement that suggests a more conservative capital structure compared to the company's historical leverage profile prior to its recent series of strategic asset divestitures.
The reduction in debt service obligations appears to provide the company with a necessary buffer to navigate ongoing legal and regulatory uncertainties, including potential PFAS-related liabilities. This improved leverage position may indicate that management is prioritizing financial stability over aggressive debt-funded expansion in the near term.
As indicated by the extreme volatility in net income, the P/E ratio is the most commonly misapplied metric for DuPont, as it obscures the underlying cash-generating capacity of the business by including non-recurring charges related to the company's ongoing structural transformation and divestiture activities.
Investors should instead focus on EV/EBITDA or free cash flow yields to better assess the operational health of the remaining specialty segments. Relying on P/E in the current context may lead to erroneous conclusions about the company's valuation, as the denominator is heavily distorted by one-time accounting adjustments.
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying DD stock.
DuPont de Nemours, Inc.'s current P/E ratio is -25.3x. The historical average is 8.4x.
DuPont de Nemours, Inc.'s current EV/EBITDA is 14.5x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 4.7x.
DuPont de Nemours, Inc.'s return on equity (ROE) is -4.1%. The historical average is 11.6%.
Based on historical data, DuPont de Nemours, Inc. is trading at a P/E of -25.3x. Compare with industry peers and growth rates for a complete picture.
DuPont de Nemours, Inc.'s current dividend yield is 3.03%.
DuPont de Nemours, Inc. has 30.3% gross margin and 12.6% operating margin. Operating margin between 10-20% is typical for established companies.
DuPont de Nemours, Inc.'s Debt/EBITDA ratio is 2.1x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.